EUVIMEDEUVIMED entdecken
Kohortenstudie

Ultra‐Long Polymyxin B Hemoperfusion and Its Effect on Vasopressor Dosage and Organ Dysfunction in Patients With Septic Shock Requiring High‐Dose Norepinephrine: A Post Hoc Analysis of a Prospective Cohort Study

Kyohei Miyamoto iD, Yu Kawazoe, Noriko Miyagawa, Hitoshi Yamamura, Yoshinori Ohta, Takuya Kimura, Yukitoshi Toyoda, Michihito Kyo, Tetsuya Sato iD, Masashi Kinjo, Masaki Takahashi iD, Junichi Maruyama und 4 weitere

Artificial Organs · 2025

DOI: 10.1111/aor.70025 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Artificial Organs, 2025. Verfasst von Kyohei Miyamoto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan. Hauptthemen laut MEDLINE: Polymyxin B, Shock, Septic, Hemoperfusion, Norepinephrine. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Wakayama Medical University, Iwate Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prolonged duration of polymyxin B hemoperfusion (PMX‐HP) for septic shock is not widely investigated.

Methods

We used BEAT‐SHOCK, a prospective registry including 309 adult patients with septic shock requiring high‐dose norepinephrine (≥ 0.2 μg/kg/min). Our post hoc analysis included 82 patients that underwent PMX‐HP, dichotomized into either the ultra‐long PMX‐HP group (first session duration ≥ 12 h; n = 53) or the non‐ultra‐long PMX‐HP group (< 12 h; n = 29). The primary outcomes were changes in vasopressor/inotrope dosage, represented by vasoactive‐inotropic score (VIS), and sequential organ failure assessment (SOFA) score from baseline to day 3.

Results

The median durations of the first PMX‐HP session in the ultra‐long and non‐ultra‐long PMX‐HP groups were 1290 and 358 min, respectively. Their median baseline VIS was 38.3 (IQR 26.0–49.5) in the ultra‐long group, 38.1 (IQR 30.9–55.6) in the non‐ultra‐long PMX‐HP group. The median baseline SOFA score was 11 (IQR 9–13) in both groups. The changes in these scores from baseline to day 3 did not differ between them (adjusted difference −3.8 [95% confidence interval −9.0 to 11.3] for VIS and −0.0 [95% confidence interval −1.5 to 1.5] for SOFA score). The 90‐day mortality rate was 24.7% in the ultra‐long PMX‐HP group and 21.1% in the non‐ultra‐long PMX‐HP group (adjusted hazard ratio 1.35; 95% confidence interval 0.49–3.69).

Conclusions

Ultra‐prolonged PMX‐HP for ≥ 12 h was not associated with a greater reduction in vasopressor/inotrope dosage or improvement in organ dysfunction on day 3 than PMX‐HP < 12 h in our patients with septic shock without endotoxin monitoring. Trial Registration UMIN Clinical Trial Registry on 1 November 2019 (registration no. UMIN000038302)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BShock, SepticHemoperfusionNorepinephrineVasoconstrictor AgentsMultiple Organ FailureAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAgedProspective StudiesOrgan Dysfunction ScoresTreatment OutcomeTime FactorsRegistries

Stichwörter der Autor:innen

adsorptionblood purificationendotoxinprolonged duration

Substanzen

Polymyxin BNorepinephrineVasoconstrictor AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan.
  • Department of Emergency and Critical Care Medicine, National Hospital Organization Sendai Medical Center, Sendai, Japan.
  • Department of Emergency and Critical Care Medicine, Osaka Minato Central Hospital, Osaka, Japan.
  • Department of Emergency and Critical Care Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Department of Emergency Medicine and Critical Care Medicine, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.
  • Department of Emergency and Critical Care Medicine, Hiratsuka City Hospital, Hiratsuka, Kanagawa, Japan.

ORCID-Profile: Kyohei Miyamoto, Tetsuya Sato, Masaki Takahashi

Förderung

  • Wakayama Medical University
  • Iwate Medical University

Zitieren

APA

Miyamoto, K., Kawazoe, Y., Miyagawa, N., Yamamura, H., Ohta, Y., Kimura, T., Toyoda, Y., Kyo, M., Sato, T., Kinjo, M., Takahashi, M., Maruyama, J., Matsuura, H., Fukushima, K., Morimoto, T., & BEAT‐SHOCK Registry Investigator (2025). Ultra‐Long Polymyxin B Hemoperfusion and Its Effect on Vasopressor Dosage and Organ Dysfunction in Patients With Septic Shock Requiring High‐Dose Norepinephrine: A Post Hoc Analysis of a Prospective Cohort Study. Artificial Organs. https://doi.org/10.1111/aor.70025

Vancouver

Miyamoto K, Kawazoe Y, Miyagawa N, Yamamura H, Ohta Y, Kimura T, et al. Ultra‐Long Polymyxin B Hemoperfusion and Its Effect on Vasopressor Dosage and Organ Dysfunction in Patients With Septic Shock Requiring High‐Dose Norepinephrine: A Post Hoc Analysis of a Prospective Cohort Study. Artificial Organs. 2025. doi:10.1111/aor.70025

BibTeX
@article{Miyamoto2025,
  author = {Miyamoto, Kyohei and Kawazoe, Yu and Miyagawa, Noriko and Yamamura, Hitoshi and Ohta, Yoshinori and Kimura, Takuya and Toyoda, Yukitoshi and Kyo, Michihito and Sato, Tetsuya and Kinjo, Masashi and Takahashi, Masaki and Maruyama, Junichi and Matsuura, Hiroshi and Fukushima, Kazunori and Morimoto, Takeshi and BEAT‐SHOCK Registry Investigator, BEAT‐SHOCK Registry Investigator},
  title = {Ultra‐Long Polymyxin B Hemoperfusion and Its Effect on Vasopressor Dosage and Organ Dysfunction in Patients With Septic Shock Requiring High‐Dose Norepinephrine: A Post Hoc Analysis of a Prospective Cohort Study},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.70025}
}
Kostenlos starten →